2026 SPS Puerto Rico | CE Evaluation

2026 SPS Puerto Rico | CE Evaluation

Event Ended

This event has ended. Registration is no longer available.

Event Schedule

June 12th, 2026 11:00 AM (EDT)
Central: June 12th, 2026 10:00 AM
Mountain: June 12th, 2026 9:00 AM
Pacific: June 12th, 2026 8:00 AM
June 13th, 2026 3:05 PM (EDT)
Central: June 13th, 2026 2:05 PM
Mountain: June 13th, 2026 1:05 PM
Pacific: June 13th, 2026 12:05 PM

Event Overview

This program focuses on the dissemination of emerging clinical evidence and comprehensive oral and intravenous pharmacotherapy management strategies across a variety of specialties.

Instructions for Credit

Thank you for attending this conference.  Your feedback is valuable to us.

To receive your Certificate of Attendance, complete and submit the Evaluation Form. Once this form is submitted your certificate will be available for download.

Registered attendees can earn a maximum of 5.75 CPE credits. You will be able to select the amount of credits being claimed.

Pharmacists: NABP e-profile number and date of birth (mm/dd/yyyy). Your CE credits will be electronically submitted to CPE Monitor® within 60 days upon successful completion of the activity.

For questions regarding credit for this activity, please contact MEC at info@meccinc.com. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Credits

  • Pharmacy5.75

Universal Activity Number(s)

Pharmacist: JA4008179-0000-26-003-L04-P

Event Details

Duration
5.75 hours
Start Date
June 12th, 2026 11:00 AM (EDT)
Central: June 12th, 2026 10:00 AM
Mountain: June 12th, 2026 9:00 AM
Pacific: June 12th, 2026 8:00 AM
End Date
June 13th, 2026 3:05 PM (EDT)
Central: June 13th, 2026 2:05 PM
Mountain: June 13th, 2026 1:05 PM
Pacific: June 13th, 2026 12:05 PM

Objectives

At the conclusion of this activity, learners should be better able to:

  • Evaluate emerging specialty pharmacotherapy options and determine their relevance to patient-specific treatment plans.

  • Apply evidence-based strategies for therapy management, monitoring, and adherence support in complex disease states.

  • Implement validated tools and processes to optimize patient adherence and therapeutic outcomes.

  • Assess opportunities to integrate biosimilars, 505(b)(2) products, and innovative therapies to enhance clinical and operational efficiency.

  • Develop collaborative strategies among pharmacists, patients, payers, and manufacturers to improve access and value in specialty pharmacy practice.

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

No Faculty or Disclosure

Disclosure

No Faculty or Disclosure

Accreditation

In support of improving patient care, The Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacist

This Knowledge-based activity has been approved for 5.75 contact hours (.575) by The Medical Educator Consortium. The Universal Activity Number for this program is JA4008179-0000-26-003-L04-P. Your CE credits will be electronically submitted to CPE Monitor® within 60 days upon successful completion of the activity. 

For any profession outside of pharmacy, contact your state or professional licensing board directly to confirm if a specific ACPE-accredited course will be accepted.